https://www.selleckchem.com/pr....oducts/act001-dmamcl
An ABP-based approach set at a 99% specificity level flagged 20/27 individuals receiving hGH treatment, including 17/27 individuals after cessation of the treatment. ABP sensitivity ranged from 12.5-71.4 % across the hGH concentrations tested following 7 days of treatment, peaking at 57.1-100 % after 21 days of treatment, and was maintained between 37.5-71.4 % for the low and high dose groups one week after cessation of treatment. These findings demonstrate that longitudinal profiling of hGH biomarkers can provide suitable perform
Like
Comment
Share
